Marcel Konrad
Director of Finance/CFO chez MEDEXUS PHARMACEUTICALS INC.
Fortune : 97 546 $ au 31/03/2024
Profil
Marcel Konrad is currently the Chief Financial Officer at Medexus Pharmaceuticals, Inc. He previously worked as the Senior VP-Finance, Accounting & Controller at CareDx, Inc. from 2018 to 2021 and as the Chief Financial Officer at Santen, Inc. from 2013 to 2018.
Mr. Konrad holds an MBA from the University of San Diego and an undergraduate degree from École des Hautes Études Commerciales de Paris.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
13/11/2023 | 80 021 ( 0,33% ) | 97 546 $ | 31/03/2024 |
Postes actifs de Marcel Konrad
Sociétés | Poste | Début |
---|---|---|
MEDEXUS PHARMACEUTICALS INC. | Director of Finance/CFO | 19/07/2021 |
Anciens postes connus de Marcel Konrad
Sociétés | Poste | Fin |
---|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Director of Finance/CFO | 01/07/2018 |
CAREDX, INC | Director of Finance/CFO | 25/03/2021 |
Formation de Marcel Konrad
University of San Diego | Masters Business Admin |
École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
CAREDX, INC | Health Technology |
MEDEXUS PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |